Literature DB >> 24219032

miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.

Qiong Li1, Chenchen Ding, Chuan Chen, Zhimin Zhang, He Xiao, Fei Xie, Lin Lei, Yuanyuan Chen, Bijing Mao, Mei Jiang, Jian Li, Dong Wang, Ge Wang.   

Abstract

BACKGROUND AND AIM: MicroRNAs (miRNAs) are small noncoding RNA molecules that control target gene expression and are implicated in the regulation of diverse cellular pathways. In our previous research, we have demonstrated that miR-224 was overexpressed in liver cancer cells and tissues, which was an important factor in the regulation of cell migration and invasion. This study aimed to further explore the regulatory mechanism of miR-224 in the migration and invasion in liver cancer cells.
METHODS: A luciferase reporter assay was used to confirm that the HOXD10 gene was a direct target of miR-224. Quantitative reverse transcriptase-polymerase chain reaction, Western blotting, Transwell migration, and Matrigel invasion assays were performed to clarify the molecular mechanism of miR-224 in the regulation of cell migration and invasion in human hepatocellular carcinoma (HCC).
RESULTS: (i) The expression of miR-224 was strongly upregulated in MHHC97H and MHCC97L cells, and its expression level was significantly associated with cell invasive potential. (ii) The HOXD10 gene was confirmed to be a direct target of miR-224. Compared with normal liver tissues and cells, HOXD10 had lower expression in HCC tissues and cells and inversely regulated HCC cell invasion. (iii) miR-224 promoted expression of the tumor invasion-associated proteins p-PAK4 and MMP-9 by directly targeting HOXD10.
CONCLUSION: Our findings suggest a previously undescribed regulatory pathway in which the miR-224/HOXD10/p-PAK4/MMP-9 signaling pathway contributes to the regulation of cell migration and invasion and provides a new biotarget for HCC treatment.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  HOXD10; human hepatocellular carcinoma (HCC); invasion; miR-224; migration

Mesh:

Substances:

Year:  2014        PMID: 24219032     DOI: 10.1111/jgh.12429

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  46 in total

Review 1.  Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.

Authors:  Yang-Guang Shao; Ke Ning; Feng Li
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Function and clinical potential of microRNAs in hepatocellular carcinoma.

Authors:  Lijuan Wang; Yongfang Yue; Xian Wang; Hongchuan Jin
Journal:  Oncol Lett       Date:  2015-09-29       Impact factor: 2.967

3.  The MicroRNA-224 Inhibitor Prevents Neuronal Apoptosis via Targeting Spastic Paraplegia 7 After Cerebral Ischemia.

Authors:  Feng Fu; Dingfeng Wu; Chao Qian
Journal:  J Mol Neurosci       Date:  2016-05-10       Impact factor: 3.444

Review 4.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

5.  MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.

Authors:  Gábor Lendvai; Tímea Szekerczés; Benedek Gyöngyösi; Krisztina Schlachter; Endre Kontsek; Adrián Pesti; Attila Patonai; Klára Werling; Ilona Kovalszky; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2018-11-09       Impact factor: 3.201

6.  MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4).

Authors:  Jing Xue; Li-Zhang Chen; Zhan-Zhan Li; Ying-yun Hu; Shi-peng Yan; Li-Ya Liu
Journal:  Mol Cell Biochem       Date:  2014-11-20       Impact factor: 3.396

Review 7.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08

8.  Prognostic gene biomarker identification in liver cancer by data mining.

Authors:  Gang Liu; Haitao Tang; Chen Li; Haiyan Zhen; Zhigang Zhang; Yongzhong Sha
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

9.  MiR-141 targets ZEB2 to suppress HCC progression.

Authors:  Shi-Min Wu; Hong-Wu Ai; Ding-Yu Zhang; Xiao-Qun Han; Qin Pan; Feng-Ling Luo; Xiao-Lian Zhang
Journal:  Tumour Biol       Date:  2014-07-10

10.  HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.

Authors:  Rafaela de Barros E Lima Bueno; Anelisa Ramão; Daniel Guariz Pinheiro; Cleidson Padua Alves; Vinicius Kannen; Achim A Jungbluth; Luiza Ferreira de Araújo; Bruna Rodrigues Muys; Aline Simoneti Fonseca; Jessica Rodrigues Plaça; Rodrigo Alexandre Panepucci; Luciano Neder; Fabiano P Saggioro; Rui Celso M Mamede; David Livingstone Alves Figueiredo; Wilson Araújo Silva
Journal:  Tumour Biol       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.